Shiseido Company, Limited (“Shiseido”) has reviewed and taken various measures, making use of its knowledge, technologies and facilities, in a policy to “consider all possibilities available to us, as a cosmetics company, to suppress the spread of the Coronavirus infection and take immediate action,” said Shiseido President and CEO Masahiko Uotani.
The brand has now developed a new hand sanitiser with special attention to sensitive and raw hands. It has started production at its Nasu Factory (Ohtawara City) from April 17 following consultation with the ministries involved. From May, the company will also start production at Osaka Factory, Kakegawa Factory and Kuki Factory. A total monthly quantity of 200,000 bottles (approximately 100,000 litres) will be supplied mainly to medical institutes and facilities in Japan.
Furthermore, the company will disclose the information (formula) for this hand sanitiser, approved by the Ministry of Health, Labor and Welfare, for other companies to use in their production as well.
The company is also currently producing disinfectant solutions outside of Japan. In France, Shiseido EMEA produces about 20,000 bottles of hydroalcoholic gel per week at its Val de Loire Factory (Orléans); and in the United States, Shiseido Americas has also started production at East Windsor Factory (New Jersey) with a first production of 85,000 bottles, each supplied to medical institutions in their respective regions.